EVEREST ORGANICS
Back to Income Statement
|
EVEREST ORGANICS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹159 Cr | ₹197 Cr | ₹183 Cr | ₹200 Cr | ₹182 Cr |
What is the latest Revenue of EVEREST ORGANICS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹159 Cr |
| Mar2024 | ₹197 Cr |
| Mar2023 | ₹183 Cr |
| Mar2022 | ₹200 Cr |
| Mar2021 | ₹182 Cr |
How is Revenue of EVEREST ORGANICS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹159 Cr | -19.15 | |
| Mar2024 | ₹197 Cr | 7.75 | |
| Mar2023 | ₹183 Cr | -8.50 | |
| Mar2022 | ₹200 Cr | 10.18 | |
| Mar2021 | ₹182 Cr | - | |
Compare Revenue of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹266.0 Cr | 6.3% | 5.5% | -32.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,104.0 Cr | 3.5% | -1.5% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,119.0 Cr | 1.1% | -1.1% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,871.0 Cr | -0.2% | -0.3% | 35% | Stock Analytics | |
| CIPLA | ₹114,334.0 Cr | 3.1% | 1% | -11.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,761.0 Cr | 1.1% | -2.1% | -5.6% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 6.3% |
5.5% |
-32.8% |
| SENSEX | 1.1% |
2.4% |
-5% |
You may also like the below Video Courses